Max Robotics — Global Service Robot Directory + US Certification

About

Yuki Maruyama is a urologic surgeon and researcher whose work focuses on advancing minimally invasive treatments for urologic cancers, particularly bladder and kidney malignancies. His major contributions center on refining robotic-assisted surgical techniques and comparing their outcomes with alternative interventions. In a pivotal 2021 study, Maruyama conducted a direct comparison of intracorporeal versus extracorporeal urinary diversion following robot-assisted radical cystectomy at a medium-sized facility, providing crucial evidence that intracorporeal diversion can be safely performed with comparable perioperative outcomes, even in non-high-volume centers. This work has garnered 9 citations and helped broaden the accessibility of complex robotic procedures. More recently, in 2024, he performed a propensity score-matched analysis comparing robot-assisted partial nephrectomy with image-guided percutaneous cryoablation for cT1 renal cell carcinoma, demonstrating that both approaches offer excellent oncologic control while highlighting distinct advantages in renal function preservation and complication profiles. With 5 citations already, this study is shaping treatment paradigms for small renal masses. Maruyama’s research is notable for its rigorous comparative methodology and its practical implications for surgical decision-making, making him a rising voice in evidence-based urologic oncology.